Fundraising Fox

Genkyotex

3 known investors

Genkyotex was a developer of NOX inhibitor therapeutics, now owned by Calliditas Therapeutics AB.

Biotech

Investors · 3

Andera PartnersParis
MC Healthcare VenturesCambridge
Vesalius Biocapital PartnersLuxembourg · $11M

In the news

Genkyotex Raises CHF 20 Million ($21 Million) | Fierce Biotechfiercebiotech.com · Jan 2015GenKyoTex S.A. Raises CHF 20 Million ($21 Million) - BioSpacebiospace.com · Jan 2015GenKyoTex S.A. Raises $26 Million for Phase II Development of Diabetic Nephropathy Drug - BioSpacebiospace.com · Jul 2012Genkyotex Raises Additional CHF25M in Series C Financing - FinSMEsfinsmes.com · Jul 2012Genkyotex Raises CHF25 Million in Series C Round Extension | Fierce Biotechfiercebiotech.com · Jul 2012

Frequently asked questions

What does Genkyotex do?
Genkyotex was a developer of NOX inhibitor therapeutics, now owned by Calliditas Therapeutics AB.
Who are Genkyotex's investors?
Genkyotex's investors include Andera Partners, MC Healthcare Ventures, Vesalius Biocapital Partners.